重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
25期
3329-3330,3384
,共3页
喻航%杨成彬%黄俊%朱正德%赖文红%伍敏%杨文
喻航%楊成彬%黃俊%硃正德%賴文紅%伍敏%楊文
유항%양성빈%황준%주정덕%뢰문홍%오민%양문
获得性免疫缺陷综合征%抗逆转录病毒治疗,高效%治疗结果
穫得性免疫缺陷綜閤徵%抗逆轉錄病毒治療,高效%治療結果
획득성면역결함종합정%항역전록병독치료,고효%치료결과
acquired immunodeficiency syndrome%antiretroviral therapy,highly active%treatment outcome
目的:了解当地艾滋病(AIDS)患者高效抗逆转录病毒治疗(HAART)效果,分析影响治疗效果的因素,提高抗病毒治疗质量。方法定期随访监测 HAART患者CD4 T淋巴细胞,观察抗病毒治疗效果。结果在24个月随访监测期中,102例抗病毒治疗患者CD4 T淋巴细胞计数逐步增加,前3个月增加较明显(P<0.01),吸毒患者和性传患者 CD4 T淋巴细胞计数组内比较差异无统计学意义(P>0.05),11例病死患者CD4 T淋巴细胞基线均数小于200个/μL,治疗3个月后CD4 T淋巴细胞计数较基线差异无统计学意义(P>0.05)。结论该群 AIDS患者 HAART的免疫学疗效不理想。
目的:瞭解噹地艾滋病(AIDS)患者高效抗逆轉錄病毒治療(HAART)效果,分析影響治療效果的因素,提高抗病毒治療質量。方法定期隨訪鑑測 HAART患者CD4 T淋巴細胞,觀察抗病毒治療效果。結果在24箇月隨訪鑑測期中,102例抗病毒治療患者CD4 T淋巴細胞計數逐步增加,前3箇月增加較明顯(P<0.01),吸毒患者和性傳患者 CD4 T淋巴細胞計數組內比較差異無統計學意義(P>0.05),11例病死患者CD4 T淋巴細胞基線均數小于200箇/μL,治療3箇月後CD4 T淋巴細胞計數較基線差異無統計學意義(P>0.05)。結論該群 AIDS患者 HAART的免疫學療效不理想。
목적:료해당지애자병(AIDS)환자고효항역전록병독치료(HAART)효과,분석영향치료효과적인소,제고항병독치료질량。방법정기수방감측 HAART환자CD4 T림파세포,관찰항병독치료효과。결과재24개월수방감측기중,102례항병독치료환자CD4 T림파세포계수축보증가,전3개월증가교명현(P<0.01),흡독환자화성전환자 CD4 T림파세포계수조내비교차이무통계학의의(P>0.05),11례병사환자CD4 T림파세포기선균수소우200개/μL,치료3개월후CD4 T림파세포계수교기선차이무통계학의의(P>0.05)。결론해군 AIDS환자 HAART적면역학료효불이상。
Objective To understand the effect of the highly active antiretroviral therapy(HAART)in the local AIDS patients and to analyzes the factors affecting the treatment effect for improving the quality of antiviral therapy.Methods The CD4 T lym-phocyte count in the patients with HAART was regularly followed-up and monitored,and the antiviral treatment effect was ob-served.Results During 24-month follow-up monitoring period,the CD4 T lymphocyte count in 102 cases of HAART was gradually increased,the increase during the first 3 months was more obvious(P<0.01),the intra-group comparison showed that CD4 T lym-phocyte count in the drug-taking patients and the sexually transmitted patients had no statistical difference(P>0.05),the baseline mean of CD4 T lymphocyte count from 11 dead patients was less than 200/μL,but the CD4 T lymphocyte count after 3-month treatment had no statistical difference compared with the baseline mean(P>0.05).Conclusion The immunological effect of HAAR in the group AIDS patients is poor.